SLC5A2 and hydrops fetalis: Agents with high (HR, 0.70; 95% CI, 0.61–0.80) and low (HR, 0.65; 95% CI, 0.57–0.75) SGLT2 selectivity reduced risk of HF hospitalization to a similar extent, with no significant difference (p = 0.47) (Fig. 2).